Загрузка страницы

Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?

Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?

Видео Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome? канала At the Limits - Leading Medical Education
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
2 декабря 2021 г. 19:29:52
00:23:18
Другие видео канала
Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyondProfessor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyondDr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - full presentationDr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - full presentationDr Sarita Naik - The management of diabetes in elderly patients with multiple co-morbiditiesDr Sarita Naik - The management of diabetes in elderly patients with multiple co-morbiditiesDr Gabrielle De Luca - The pathology of secondary progressive MSDr Gabrielle De Luca - The pathology of secondary progressive MSDr Marc Pfeffer - HFpEF: looking back - forging forward - Full versionDr Marc Pfeffer - HFpEF: looking back - forging forward - Full versionProfessor Jeremy Chataway - Octopus - inside the progressive MS mega-trialProfessor Jeremy Chataway - Octopus - inside the progressive MS mega-trialDr Ellen Mowry - Diet and MS courseDr Ellen Mowry - Diet and MS courseProfessor Robert A Hegele - The new genetics & therapies of dyslipidemiasProfessor Robert A Hegele - The new genetics & therapies of dyslipidemiasProfessor Mansoor Husain - GLP-1 analogues - have the limits been reached? - Full versionProfessor Mansoor Husain - GLP-1 analogues - have the limits been reached? - Full versionProfessor Miles Fisher - The role of GLP-1 – clinical trial evidence & future prospects.Professor Miles Fisher - The role of GLP-1 – clinical trial evidence & future prospects.Professor Basil Sharrack and Professor John Snowden - AHSCT and the management of MSProfessor Basil Sharrack and Professor John Snowden - AHSCT and the management of MSProfessor Sean Wharton - The science of obesity, where might this lead clinical practice?Professor Sean Wharton - The science of obesity, where might this lead clinical practice?Professor Christopher Wilcox - Diuretic resistance - new tricks for an old problem - Full versionProfessor Christopher Wilcox - Diuretic resistance - new tricks for an old problem - Full versionProfessor John Deanfield - Cardiologia primordial na juventude – quais são os limites?Professor John Deanfield - Cardiologia primordial na juventude – quais são os limites?Miranda Olding - The value of nurse prescribing in the management of people with MSMiranda Olding - The value of nurse prescribing in the management of people with MSProfessor Dimitrios Karussis - 'Mesenchymal stem cell transplantation in MS'Professor Dimitrios Karussis - 'Mesenchymal stem cell transplantation in MS'Debate  a new era in the management of type 2 diabetes & cardiorenal diseaseDebate a new era in the management of type 2 diabetes & cardiorenal diseaseProfessor Karl S  Peggs - Tumour neoantigens – the next frontier?Professor Karl S Peggs - Tumour neoantigens – the next frontier?Professor John McMurray - Terapia para insuficiência cardíaca - ampliando os limites!Professor John McMurray - Terapia para insuficiência cardíaca - ampliando os limites!Professor Marc Pfeffer - Surprising findings from clinical trials – cardio, diabetes & nephrologyProfessor Marc Pfeffer - Surprising findings from clinical trials – cardio, diabetes & nephrologyDr Laura Piccio - Immunological effect of caloric restriction in MS and EAEDr Laura Piccio - Immunological effect of caloric restriction in MS and EAE
Яндекс.Метрика